Who We Are

“Our participation within the Working Group of National Co-ordinators of the Test Guidelines programme (WNT) allows us to support the advancement of NAMs by working towards their adoption into OECD Test Guidelines. As a leading member of the expert group on respiratory sensitization, I facilitate the awareness and development of some of the most advanced human specific, non-animal methods in the field. Working within the scientific rigor of the OECD Secretariat and member countries, we can achieve global harmonization of these methods. This is crucial to prevent the continued use of outdated animal-based methods, and to replace them with more effective and ethical science worldwide.”

Eryn Slankster-Schmierer, PhD
Regulatory Testing Specialist
Physicians Committee for Responsible Medicine 

“As a representative of ICAPO, I am a member of the OECD Validation Management Group for Ecotoxicity Testing (VMG-Eco) which develops internationally accepted test guidelines and guidance documents for the regulatory testing of industrial chemicals, plant protection products, and more. My work involves co-leading two OECD Test Guidelines Programme projects aiming at predicting acute fish toxicity and reducing the number of fish in selected test guidelines if a solvent is used. Together with OECD member countries, we’re shaping the future of ecotoxicity testing to reduce reliance on animal testing while safeguarding human and ecological health.”

Christopher Faßbender, PhD
Ecotoxicologist
PETA Science Consortium International e.V.

“As an ICAPO representative, I engage actively in OECD Working Party initiatives, leveraging my expertise in cardiotoxicity, systemic toxicity, QSAR modeling, IVIVE/PBPK frameworks, and integrated non-animal testing strategies. Through these efforts I aim to advance human-relevant alternatives that replace outdated animal tests, supporting international harmonization and regulatory acceptance of non-animal methods.”

Shagun Krishna, PhD 
Director
Toxicology Physicians Committee for Responsible Medicine

“OECD Working Party on Manufactured Nanoparticles (WPMN) meetings provide an international platform for harmonisation of testing strategies that allow for efficient and effective assessment of the vast number of nanomaterials on the market. As a representative of ICAPO, I am able to promote robust in vitro testing approaches that protect human health and the environment.”

Monita Sharma, PhD
Nanotechnology Specialist
PETA Science Consortium International e.V.

"It is a pleasure representing ICAPO in the Expert Group on Skin and Eye Irritation/Phototoxicity, and the Expert Group on Skin Sensitization, where OECD member countries work together with other scientific experts to ensure that the new non-animal methods coming through the pipeline are robust, relevant and ultimately useful for regulatory decision making. With the skin and eye endpoints, we’re in the fantastic position of having lots of choice of methods, many of which have been demonstrated to be as or more relevant and reliable than the traditional test methods, which use rabbits, mice and guinea pigs."

Anna van der Zalm, MChem
Scientific Specialist
PETA Science Consortium International e.V.